Table 4.

Descriptive Statistics of Secondary and Additional Measures

Variable	Avocado Supplemented Diet Group (n=505)			Habitual Diet Group (n=503)
	Baseline	Intervention		Baseline	Intervention
		3 mo	6 mo		3 mo	6 mo
Anthropometric
Body weight, kg	93.2±19.0	93.8±19.3	93.4±19.4	93.1±18.9	93.6±19.1	93.4±19.1
Body mass index, kg/m2	32.9±5.3	33.1±5.5	33.0±5.5	33.2±5.6	33.3±5.7	33.2±5.6
Waist circumference, cm*
Women	106.0±11.9	106.1±12.2	106.3±12.6	106.6±12.2	106.6±12.6	106.3±3.0
Men	117.6±11.5	117.6±11.8	116.8±12.0	117.6±12.2	117.6±12.6	117.2±12.7
Cardiometabolic risk factors
Systolic BP, mm Hg*	123±16	121±15	122±16	123±16	122±15	123±16
Diastolic BP, mm Hg*	77±10	75±10	76±15	76±11	76±10	76±10
High‐sensitivity C‐reactive protein, mg/L*	3.7 (1.5–7.8)	3.7 (1.5–7.6)	3.6 (1.6–7.6)	3.7 (1.6–7.3)	3.7 (1.4–7.7)	3.8 (1.6–7.9)
Total cholesterol, mg/dL†	185±40	181±40	180±38	190±39	189±40	189±38
LDL‐cholesterol, mg/dL†	110±34	106±33	104±33	114±34	112±34	111±33
HDL‐cholesterol, mg/dL*
Women	55±13	55±13	54±13	56±13	56±12	56±13
Men	44±9	45±10	44±9	45±10	46±11	46±11
Very LDL‐cholesterol, mg/dL	21 (16–29)	20 (15–29)	21 (15–30)	21 (15–29)	21 (15–30)	21 (16–29)
Triglyceride, mg/dL*	106 (79–145)	102 (73–144)	103 (75–148)	104 (73–145)	105 (76–149)	104 (80–146)
Total cholesterol:HDL‐cholesterol	3.8±1.0	3.7±1.1	3.7±1.0	3.7±1.0	3.7±1.0	3.7±1.0
Glucose, mg/dL*	100 (93–109)	100 (93–108)	101 (94–111)	101 (93–110)	100 (93–109)	101 (94–110)
Insulin, μIU/mL†	14 (9–20)	14 (9–20)	13 (9–21)	13 (8–21)	13 (9–22)	13 (8–22)

Data are presented as mean±SD, or median (interquartile range). BP indicates blood pressure; HDL, high‐density lipoprotein; and LDL, low‐density lipoprotein.

^*Secondary outcome.

^† Additional prespecified outcome.